This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sugen Incorporated. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Innovations in Pharmaceutical Formulations by Waranush Sorasuchart
Introduction
Waranush Sorasuchart is an innovative inventor based in Bangkok, Thailand, known for his contributions to the field of pharmaceutical formulations. With a unique patent to his name, he has made significant strides in the development of agents that are ionizable as free acids or free bases.
Latest Patents
Waranush holds a patent for "Formulations for pharmaceutical agents ionizable as free acids or free bases." This patent focuses on formulations of indolinones which are crucial for medical applications. The invention outlines a formulation suitable for both parenteral and oral administration. It comprises ionizable substituted indolinones, which include pyrrole substituted 2-indolinones. These compounds are characterized by hydrocarbon chains that possess polar groups, making them effective in treating protein kinase-related disorders.
Career Highlights
Throughout his career, Waranush Sorasuchart has been associated with Sugen Incorporated, where he focuses on research and development in pharmaceutical sciences. His expertise in formulating effective drug therapies has positioned him as a prominent inventor in his field.
Collaborations
Waranush has collaborated with notable colleagues such as Narmada R Shenoy and Arun Koparkar. These partnerships have played a vital role in enhancing his research and expanding the scope of his innovative endeavors.
Conclusion
Waranush Sorasuchart's inventive work in pharmaceutical formulations highlights the importance of innovation in medicine. His contributions, particularly in developing agents for treating protein kinase-related disorders, reflect the potential of tailored drug therapies. As he continues to advance in his career, his ongoing research promises to impact healthcare positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
